New hope for advanced cancer patients: experimental drug ABX-001 enters human trials
Disease control
Recruiting now
This early-phase study tests a new drug called ABX-001, given alone or with the immunotherapy pembrolizumab, in adults with advanced solid tumors that no longer respond to standard treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tu…
Phase: PHASE1 • Sponsor: Abalos Therapeutics GmbH • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC